Dr. Ashwaq Alolayan

Consultant of Medical Oncology

Consultant of Medical Oncology,

King Abdulaziz Medical City, Riyadh.

14 : 30 – 14 : 40

24 June | 2023 Day 2

NRG/RTOG 1112: Randomized phase III study of sorafenib vs. stereotactic body radiation therapy (SBRT) followed by sorafenib in hepatocellular carcinoma (HCC).

4th PSMMC ASCO Data Review Meeting (PADRM). This meeting will highlight the top most clinically relevant achievements of ASCO 2023 for different and commonest tumor types.